CDC Alters Kids' Vaccine Recommendation
CDC Temporarily Defers a Booster Shot for Hib Vaccine Due to Hib Vaccine Recall
Dec. 19, 2007 -- The CDC today announced a temporary change to its
recommendations for a common childhood vaccine.
The vaccine is the Haemophilus influenzae type b vaccine (Hib
For now, the CDC has deferred the Hib vaccine booster shot for most kids
aged 12-15 months due to a recall-related shortage of the vaccine.
There are some exceptions. Kids at high risk for Hib -- including children
with sickle cell disease, HIV, cancer, and American
Indian/Alaska Native children -- should still get the Hib vaccine booster shot
at ages 12-15 months.
Last week, the drug company Merck
recalled 1.2 million doses of its Hib vaccines -- PedvaxHIB and Comvax --
because of concerns about product sterility. The recall was a precaution;
no tainted vaccines have been found.
The drug company Sanofi Aventis also makes Hib vaccines. Those vaccines
haven't been recalled. But Sanofi Aventis likely can't provide enough of its
Hib vaccines right away to cover the recall-related shortage, according to the
The Haemophilus influenzae type b vaccine (Hib vaccine) prevents
serious bacterial infections, including:
Meningitis, an infection of the
covering of the brain and spinal cord
- Pneumonia, a lung infection
The CDC recommends the Hib vaccine for all children under 5 years old in the
U.S., with doses starting when children are 2 months old. The Hib vaccine isn't
related to the flu vaccine.